Manhattan Office Assets Flood the Market as Investment Sales Momentum Builds

Manhattan Office Assets Flood the Market as Investment Sales Momentum Builds

A cluster of high-profile Midtown office buildings has hit the sale block in quick succession this summer, a burst of listing activity that underscores how quickly New York’s office investment sales market has thawed.

The run began in July, when BXP, Inc. put its ground-lease interest at 7 Times Square up for sale, seeking north of $700 million for its stake in the 1.2 million-square-foot property. Days later, Empire State Realty Trust listed 1359 Broadway with hopes of roughly $225 million, while Property & Building Corporation relaunched its effort to sell 10 Bryant Park at an ask above $800 million — a second attempt after a prior $855 million deal collapsed in 2022. Shortly afterward, the estate of L.H. Charney closed a sale of 1441 Broadway to a partnership of 60 Guilders and Sentry Realty for $238 million.

Deal flow carried into August. Tishman Speyer brought 6 Grand Central, a 770,386-square-foot trophy tower, to market asking about $450 million, and China Life Insurance Group began marketing its minority stake in RXR’s 1285 Sixth Avenue at a price implying a $1.4 billion building valuation. Around the same time, Thor Equities agreed to acquire ESRT’s 22-story 1359 Broadway for $218 million — slightly below the original asking figure, but a completed trade nonetheless.

Context: a broader rebound

The flurry of listings follows a strong 2025, when New York City office investment climbed 30 percent to top $11 billion, according to an analysis by Jones Lang LaSalle Incorporated. At the time, analysts suggested institutional capital was shifting from cautious observation toward selective re-engagement, targeting well-leased assets in established submarkets.

Recent activity appears consistent with that thesis. Nearly all of the nine-figure towers to surface in recent months sit in prime Midtown or Midtown South corridors and report tenant occupancy of at least 90 percent. Manhattan office sales reached $2.3 billion in the second quarter, per Cushman & Wakefield — a 42 percent increase over the year-ago period and in line with the five-year quarterly average.

The pattern suggests sellers are testing whether the renewed appetite can support pricing, while buyers appear willing to transact for stabilized, heavily leased product. BXP shares traded recently at $67.69, down 0.79 percent from the prior close of $68.23, valuing the office REIT at roughly $12.2 billion. JLL, whose research has tracked the recovery, recently changed hands at $362.36, essentially flat on the day, for a market capitalization of about $16.5 billion.

What to watch

• Final pricing on 7 Times Square, 10 Bryant Park, 6 Grand Central, and the 1285 Sixth Avenue stake relative to asking figures
• Whether Q3 Manhattan office sales volume sustains the Q2 pace
• Upcoming earnings reports from BXP and JLL for commentary on capital markets conditions and asset valuations

Source: original release